14-88416725-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018418.5(SPATA7):c.253C>T(p.Arg85*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,612,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018418.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA7 | NM_018418.5 | c.253C>T | p.Arg85* | stop_gained | 5/12 | ENST00000393545.9 | NP_060888.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA7 | ENST00000393545.9 | c.253C>T | p.Arg85* | stop_gained | 5/12 | 1 | NM_018418.5 | ENSP00000377176.4 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151856Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000719 AC: 18AN: 250440Hom.: 0 AF XY: 0.0000812 AC XY: 11AN XY: 135504
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1460952Hom.: 0 Cov.: 30 AF XY: 0.0000537 AC XY: 39AN XY: 726750
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151856Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74158
ClinVar
Submissions by phenotype
Leber congenital amaurosis 3 Pathogenic:4
Pathogenic, no assertion criteria provided | literature only | OMIM | May 09, 2011 | - - |
Pathogenic, no assertion criteria provided | research | Laboratory of Genetics in Ophthalmology, Institut Imagine | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 18, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 23, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 30806). This premature translational stop signal has been observed in individual(s) with inherited retinal disease (PMID: 21310915, 25133751). This variant is present in population databases (rs140287375, gnomAD 0.05%). This sequence change creates a premature translational stop signal (p.Arg85*) in the SPATA7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPATA7 are known to be pathogenic (PMID: 19268277, 22334370, 23847139, 26047050, 26261414). - |
Retinal dystrophy Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Nov 08, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2017 | - - |
Pathogenic, criteria provided, single submitter | research | Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel | May 27, 2024 | - - |
SPATA7-related disorder Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 09, 2024 | The SPATA7 c.253C>T variant is predicted to result in premature protein termination (p.Arg85*). This variant has been reported many times in both the homozygous and compound heterozygous states in individuals with Leber congenital amaurosis (see for examples: Mackay et al. 2011. PubMed ID: 21310915; Table S2, Liu et al. 2020. PubMed ID: 33090715; Table S1, Lin et al. 2024. PubMed ID: 38219857). This variant is reported in 0.053% of alleles in individuals of South Asian descent in gnomAD. Nonsense variants in SPATA7 are an established mechanism of disease. This variant is interpreted as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 12, 2018 | The SPATA7 c.253C>T (p.Arg85Ter) variant is a stop-gained variant that is predicted to result in premature termination of the protein. The p.Arg85Ter variant has been reported three studies in which it is found in a homozygous state in a total of five affected individuals from four unrelated families (Mackay et al. 2011; Avila-Fernandez et al. 2011; Watson et al. 2014). These individuals presented with a range of phenotypes of ocular dystrophies including Leber congenital amaurosis, late onset retinal pigmentosa, and cone rod dystrophy. Control data are unavailable for this variant, which is reported at a frequency of 0.000364 in the South Asian population of the Genome Aggregation Database. Based on the potential impact of stop-gained variants and clinical evidence, the p.Arg85Ter variant is classified as likely pathogenic for SPATA7-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Retinitis pigmentosa 94, variable age at onset Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 09, 2011 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 09, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 22136677, 25525159, 21310915, 25133751, 33173045, 31589614, 33090715) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at